Related Experiment Video
Updated: Jun 16, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
TNF in host resistance to tuberculosis infection
Valerie F J Quesniaux1, Muazzam Jacobs, Nasiema Allie
1Molecular Immunology and Embryology UMR6218, Orleans University and CNRS, Orleans, France. quesniaux@cnrs-orleans.fr
Tumor necrosis factor (TNF) is vital for controlling tuberculosis infections. Membrane-bound TNF alone can manage acute Mycobacterium tuberculosis infection, suggesting targeted therapies could reduce risks.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Tumor necrosis factor (TNF) plays a critical role in controlling Mycobacterium tuberculosis (M. tuberculosis) infection.
- Dysregulated TNF production can lead to immunopathology or uncontrolled infection.
- Anti-TNF therapies for autoimmune diseases have revealed TNF's importance in tuberculosis (TB) control.
Purpose of the Study:
- To review recent studies on the molecular, cellular, and kinetic aspects of TNF-mediated regulation of host-M. tuberculosis interactions.
- To explore the potential for selective TNF neutralization in managing TB while minimizing risks.
Main Methods:
- Analysis of studies using mutant mice expressing only membrane TNF.
- Investigation of specific inhibitors that spare membrane TNF.
- Review of clinical observations in patients undergoing anti-TNF therapy.
Main Results:
- Membrane-bound TNF is sufficient for controlling acute M. tuberculosis infection.
- Selective neutralization of TNF may offer therapeutic benefits.
- Understanding TNF's role is crucial for managing TB and associated inflammatory conditions.
Conclusions:
- Targeting membrane TNF could provide a therapeutic strategy for tuberculosis.
- Selective TNF inhibition may balance anti-inflammatory effects with reduced infectious risk.
- Further research into TNF's mechanisms in host-pathogen interactions is warranted.
More Related Videos
07:42Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Tuberculosis
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: